Objective Age is known to influence the risk of both cerebral ischemic lesions and impaired cognitive function. Diabetes mellitus (DM) can also be associated with cognitive impairment. However, there has been no study of neuropsychological performance in association with glucose metabolism status and cerebral ischemic lesions in same-aged, community-dwelling elderly persons. The present study was performed to clarify which cognitive domains are associated with impaired glucose metabolism/DM and whether the association is independent of cerebral ischemic lesions. Subjects and Methods A total of 172 residents in Takahata, Japan, all of whom were 78 years old, were evaluated in multiple domains through neuropsychological tests and brain MR images, as well as a medical check-up including tests for glucose metabolism status and conventional vascular risk factors. Glucose metabolism status was determined by analysis of HbA1c level. Results In multiple regression analyses, performance on a verbal fluency (VF) test and the Trail Making Test-Part B, both of which represent executive function, was associated with HbA1c level, even after adjustment for sex, education, cerebral ischemic lesions, and conventional vascular risk factors. The subjects with DM also showed lower VF scores than did those without DM.
Introduction
Over the past two decades or more, an increase in the number of individuals with dementia has been a growing problem worldwide. In the absence of a curative treatment for dementia, the identification of risk factors for impaired cognition may contribute to the prevention or slowing of cognitive decline. Since the conventional vascular risk factors are closely associated with the development of ischemic lesions in the brain, these factors may contribute to the progression of cognitive dysfunction in the elderly (1) . Previous studies have suggested that diabetes mellitus (DM) is related to dementia (2-6) or cognitive impairment (7) . Cerebral ischemic lesions of small vessel origin [small vessel disease (SVD)-related lesions], such as cerebral white matter lesions (WMLs) and lacunar infarcts (LI), which are frequently observed in the elderly brain on magnetic resonance imaging (MRI), are also associated with cognitive dysfunction (8, 9) . Therefore, SVD-related lesions should be considered in any investigation of the relationship between DM and cognitive dysfunction. However, there has been no study to examine diabetes-associated cognitive dysfunction under consideration of SVD-related lesions in community-dwelling elderly individuals. Furthermore, although age is known to have an influence on both SVD-related lesions (10) and neuropsychological tests (11) , there has been no study of same-age subjects.
In the present study, to exclude the influence of age differences on the results of neuropsychological tests and brain MRI examination, we recruited and examined elderly individuals of the same age (78 years) living in a Japanese community. To evaluate SVD-related lesions in the brain, all the participants underwent MRI examination. We also performed comprehensive neuropsychological tests to determine which cognitive domains may be affected by impaired glucose metabolism/DM.
Subjects and Methods

Subjects
The protocol and number of the participants are summarized in Fig. 1 . In 2000, we introduced a prospective, community-based study to evaluate risk factors for cerebrovascular disease and dementia-type illness using brain MRI. All of the participants were 70-year-old residents in Takahata, Yamagata Prefecture, Japan. In addition to the medical interviews regarding their history of cerebrovascular diseases, hypertension, diabetes and dyslipidemia as well as smoking habits and alcohol consumption, the health check examination included blood pressure measurements and neurological examination. Furthermore, biochemical examinations including HbA1c and electrocardiograms were also performed. At the baseline examination in 2000, each subject underwent the Mini-Mental State Examination (MMSE) and Hasegawa dementia Scale-revised (HDS-R) as a global measure for cognitive function. Eight years later, in 2008, the same residents, at the age of 78 years, were invited to participate again (n=236). A total of 188 (79.7%) residents agreed to participate, with 172 participants being evaluated for cognitive function, conventional vascular risk factors, and brain MRI findings. Each subject gave written informed consent to participate in the present study, which was approved by the Medical Ethics Committee of the Yamagata University Faculty of Medicine.
Methods
Interviews
Clinical information including the educational level, medical history, smoking habits, and alcohol consumption of each subject was obtained during face-to-face interviews. Alcohol consumption was calculated on the basis of ethanol volume; heavy drinkers were defined as those who consumed more than 210 g of ethanol weekly (12) .
Evaluation of conventional vascular risk factors
In the present study, hypertension (HT) was defined as a casual blood pressure (BP) of 140/90 mmHg or the use of medication for HT. Hyperlipidemia (HLp) was defined as a total cholesterol level of 220 mg/dL or the use of medication for HLp. Subjects who indicated having HT or HLp in both 2000 (initial examination) and 2008 (subsequent examination) were defined as HT-8y (HT over 8-year duration) Values are numbers, percentages, or unadjusted means (SD).
or HLp-8y (HLp over 8-year duration), respectively. According to the criterion of the American Diabetes Association (13), DM was defined as a hemoglobin A1c (HbA1c) level of 6.5%; however, because the HbA1c value as measured in Japan is 0.4% lower than that reported by the National Glycoprotein Standardization Program in the USA (14), we defined DM as HbA1c 6.1% (the Japan Diabetes Society-assigned HbA1c values) or the use of medication for DM. Subjects who indicated having DM in both 2000 and 2008 were defined as DM-8y (DM over 8-year duration). In addition, chronic kidney disease (CKD) was defined as an estimated glomerular filtration rate (eGFR) of <60 mL/min per 1.73 m 2 . The eGFR was calculated from the serum creatinine value and age using the abbreviated Modification of Diet in Renal Disease equation modified by the Japanese coefficient (15) .
Assessment of brain MRI scans
Axial T1-, T2-weighted, and fluid-attenuated inversion recovery (FLAIR) images were collected from each subject in our study. Four trained neurologists who were blind to the clinical information of each subject evaluated SVD-related lesions on MR images. If raters disagreed over the findings for any of the subjects, they met to reach a consensus. LI was defined as a hypo-signal intensity area (3 to 15 mm) on T1-weighted images that was also visible as a hyper-signal intensity area on T2-weighted images (16) . WML was defined as at least one focal lesion in the cerebral white matter with corresponding hyperintensity on FLAIR images. The Fazekas scale was used to evaluate the severity (grades 0-3) of WML because this scale has been shown to reflect the pathological severity of cerebral SVD in post-mortem examinations (17) .
Neuropsychological tests
Cognitive function is composed of multiple cognitive domains, such as memory, information processing speed, attention, and executive function. To select the neuropsychological tests for this study, we reviewed investigations in which comprehensive cognitive examinations were used to study elderly subjects. We then selected frequently used instruments. The tasks performed in this study were as follows: 1) the MMSE (18) as a global measure of cognitive function; 2) the HDS-R (19) as a global measure of cognitive function; 3) verbal fluency (VF) as a measure of executive function; 4) digit span (forward and backward) as a measure of attention and working memory; 5) visual memory span (forward and backward) as a measure of attention and working memory; 6) the Trail Making Test-Part A (TMT-A) as a measure of psychomotor speed; 7) the Trail Making TestPart B (TMT-B) (20) as a measure of executive function; and 8) counting from 1 to 20 or counting from 20 to 1 as a measure of attention and psychomotor speed. In the VF test, participants were asked to name as many animals or vegetables as possible (category fluency) or as many Japanese words beginning with 'Ka' or 'A' as possible within 1 min (phonemic fluency). Counting from 20 to 1, digit span, and visual memory span are subtests of the Japanese version of the Wechsler Memory Scale-Revised. Digit span and visual memory span were evaluated using raw scores.
Statistical analysis
To address the relationship between impaired glucose metabolism and multiple cognitive domains, all the test scores were analyzed as continuous variables. To examine the impact of impaired glucose metabolism on neuropsychological performance, multiple regression analyses in a saturated model were performed in our study. The presence of LI and the severity of WML were handled as separate multiple regression models. Multiple regression analyses were adjusted for sex, education, HbA1c, hemoglobin, body mass index, HT-8y, HLp-8y, past history of stroke, past history of coronary heart disease, smoking habit, heavy drinking, CKD, and LI or WMLs. Multicollinearity among these explanatory variables was checked based on the variance inflation factors (VIFs). Since the treatment of DM, which could decrease HbA1c levels, may potentially influence the results, we also performed multiple regression analysis using DM-8y instead of HbA1c values. A probability value of <0.05 was considered significant. All analyses were performed using the R package 2.9.0 (http://www.r-project.org/).
Results
Of the 188 residents invited to participate in the study, 16 subjects were excluded because they refused the neuropsychological evaluation (n=14) or because of MRI contraindications (n=2) (Fig. 1) . The clinical characteristics of the subjects are summarized in Table 1 . The prevalence rates for HT and diabetes were 86.8% and 16.9%, respectively. The prevalence rate for LI was 36.0%, and those of WML were 59.9% in grade 1, 22.7% in grade 2, and 6.4% in grade 3. According to the correlation matrix of the variables (data not shown), the largest absolute value of the correlation coefficients was -0.73 for smoking habit and sex; however, there were no clinical parameters with a VIF greater than five, indicating that our multiple regression models were not ill-conditioned because of multicollinearity.
The mean values for the neuropsychological tests are summarized in Table 2 . The highest number of missing values (19 participants) was observed on the TMT-B: the 19 individuals did not understand how to perform or could not complete the examination. Two participants could not count from 20 to 1, and six participants were unable to complete the TMT-A. To evaluate the relationship between the clinical parameters and the neuropsychological examination scores, we replaced the scores of the subjects who could not accomplish these tests with the worst score of the study groups.
The association of clinical parameters, including SVDrelated lesions, with neuropsychological test scores is summarized in Table 3 , 4. The HbA1c levels were significantly associated with the scores for VF (category fluency) and the TMT-B. The significant association persisted even after adjustment for education, BMI, hyperlipidemia, HT-8y, SVDrelated lesions (LI and WML), and other vascular risk factors. Higher grades of WML were significantly associated with lower scores of the VF (category fluency) and the TMT-B, independently of HbA1c values.
Next, we examined whether DM-8y was associated with 
Discussion
The results of the present community-based study of same-aged Japanese elderly persons who underwent multiple cognitive function tests indicate impaired glucose metabolism/DM as a significant risk factor for cognitive dysfunction. The significant association persisted even after adjustment for education, conventional vascular risk factors, and cerebral SVD-related lesions. Because all the subjects evaluated in the study were the same age (78 years), the influence of chronological age on neuropsychological performance and cerebral SVD-related lesions (LI and WML) on MRI was excluded. The relationships among impaired glucose metabolism, cerebral SVD-related lesions on MRI, and multiple cognitive domains among community-dwelling elderly have not been reported. To the best of our knowledge, this report is the first in which impaired glucose metabolism/DM in late life, independent of cerebral ischemic lesions, is shown to be a significant risk factor for cognitive dysfunction in community-dwelling Japanese elderly persons.
The results of the Leukoaraiosis and Disability (LADIS) study, a multinational, prospective, clinic-and hospital-based study investigating the impact of WMLs on the transition to disability in the elderly (21) , demonstrated that DM predicted cognitive impairment independently of the severity of WMLs (22) . The differences between the LADIS study and ours are that 1) all the participants in the LADIS study had WMLs and were clinic or hospital patients, whereas our subjects were elderly residents, with or without WMLs, in a community; 2) the ages of LADIS subjects ranged from 65 to 84 years, whereas our subjects were all 78 years of age; 3) the LADIS participants were from various ethnic and language backgrounds, which could have affected the results of the neuropsychological tests, whereas we examined only Japanese subjects; and 4) the glycemic conditions of the LADIS participants were classified as DM or non-DM, whereas we used both continuous variables (HbA1c levels) and categorical variables (DM or non-DM). In spite of these differences, the results of the LADIS study and the present study indicate that impaired glucose metabolism or DM, independent of cerebral ischemic lesions, significantly increases the risk for cognitive dysfunction in the elderly. The results of some epidemiological studies (2-5) indicated that diabetes-associated cognitive impairment might be due to Alzheimer's Disease (AD), while the results of other studies (23) (24) (25) (26) (27) found no such association. Since AD is a pathological disease entity (28) , pathological studies are essential to ascertain the possible association of DM with AD. Only five pathological studies have been reported that examined the relationship between DM and AD pathology (4, (29) (30) (31) (32) . Four of the studies demonstrated no significant difference between subjects with and without DM in terms of AD pathology, including neuritic plaques and neurofibrillary tangles (4, (29) (30) (31) . One of the four studies even showed that DM was negatively associated with AD pathology: the subjects with DM had significantly less AD pathology than did those without DM (29) . On the other hand, the remaining study demonstrated a significant association of insulin resistance, a DM-associated condition, with the presence of neuritic plaques; however, even in that study, no dose-response relationship between neuritic plaques and insulin resistance was observed. Furthermore, no association of any DM-related condition with neurofibrillary tangles, an essential component of AD pathology, was found in the study (30) . Indeed, Heitner and Dickson noted that factors other than AD were responsible for cognitive impairment in individuals with DM (31) . It has been reported that a decline in episodic memory, such as impaired recall of three items on the MMSE, is an initial neuropsychological change in AD (33) . In the present study, however, impaired glucose metabolism/DM was not associated with a decline in memory function but with decreased executive function (VF and TMT-B) (34) . Therefore, the pattern of neuropsychological abnormality in diabetes-associated cognitive impairment may be different from that of AD. This notion is supported by the results of a cohort study for community-dwelling elderly showing that DM is significantly associated with mild cognitive impairment without memory disturbance (35) . The brain depends completely on glucose: the glucose consumption of the brain (per weight of organ) is the greatest among all organs of the body. In the clinical setting, the brain is most severely affected by abnormalities in glucose metabolism, which can lead to hypoglycemic or hyperglycemic coma. Therefore, it is plausible that a mild or moderate impairment of glucose metabolism may cause neuronal dysfunction, even without cerebral ischemic lesions or AD pathology, over a long period of time. In the present study, subjects with impaired glucose metabolism required a significantly longer time to complete the VF test and TMT-B, indicating that slowed executive function may be an initial manifestation of brain dysfunction caused by impaired glucose metabolism.
There are some potential limitations to our study. First, we did not assess brain atrophy on MRI, which may be related to worse performance of cognition. Brain atrophy due to cerebrovascular diseases or to neurodegenerative diseases may potentially influence the results of our study. In the present study, however, no participants with clinical stroke or neurodegenerative diseases were found by neurological and brain MRI examinations. Second, we included only 78-year-old residents in our study in order to exclude the effect of the difference of chronological age on the results of brain MRI and neuropsychological examinations. This selection of a specific age group may potentially cause a bias: strictly speaking, the present results could be applied only to the 78-year-old residents, but not to other age groups, such as younger elderly. Third, we did not evaluate the degree of insulin resistance, which may lead to vascular diseases or dementia (36, 37) . Fourth, we did not examine genetic factors. It is possible that the APOE genotypes may influence cognitive function in subjects with DM.
In conclusion, the results of the present study demonstrate a significant association of impaired glucose metabolism with slow executive function independent of cerebral ischemic lesions on MRI. The pattern of neuropsychological abnormality in diabetes-associated cognitive impairment was different from that of AD. Therefore, it is possible that slowness of executive function without memory disturbance may be an initial manifestation of cognitive dysfunction in individuals with impaired glucose metabolism/DM. Further studies are needed to elucidate the exact pathophysiological and biochemical mechanisms of cognitive impairment associated with impaired glucose metabolism/DM.
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